No need to stop oestrogen before gender-affirming surgery: study

Transfeminine patients remaining on the hormone do not appear to be at greater risk of VTE, authors report
Reuters Health Staff writer
trasngender symbol

Transgender women can safely maintain their oestrogen hormone therapy during gender-affirming surgery without an increased risk of venous thromboembolism (VTE), a study shows.

US researchers examined VTE risk associated with suspending versus continuing oestrogen therapy in the perioperative period for gender-affirming surgeries.